Morgan Stanley 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-03 1:59 pm Purchase |
2024-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
MORGAN STANLEY MS |
3,828,810 5.400% |
3,828,810 (New Position) |
Filing |